scholarly journals Effect of oral premedication on the anaesthetic efficacy of inferior alveolar nerve block in patients with irreversible pulpitis - A systematic review and network meta-analysis of randomized controlled trials

2018 ◽  
Vol 51 (9) ◽  
pp. 989-1004 ◽  
Author(s):  
S. J. Pulikkotil ◽  
V. Nagendrababu ◽  
S. K. Veettil ◽  
P. Jinatongthai ◽  
F. C. Setzer
Keyword(s):  
Systematic Review ◽  
Randomized Controlled Trials ◽  
Nerve Block ◽  
Meta Analysis ◽  
Inferior Alveolar Nerve ◽  
Controlled Trials ◽  
Inferior Alveolar Nerve Block ◽  
Randomized Controlled ◽  
Oral Premedication ◽  
Irreversible Pulpitis

Efficacy and Safety of Oral Premedication on Pain after Nonsurgical Root Canal Treatment: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials

2019 ◽  
Vol 45 (4) ◽  
pp. 364-371 ◽  
Author(s):  
Venkateshbabu Nagendrababu ◽  
Shaju Jacob Pulikkotil ◽  
Peerawat Jinatongthai ◽  
Sajesh K. Veettil ◽  
Nattawat Teerawattanapong ◽  
...  
Keyword(s):  
Systematic Review ◽  
Randomized Controlled Trials ◽  
Root Canal ◽  
Meta Analysis ◽  
Root Canal Treatment ◽  
Controlled Trials ◽  
Efficacy And Safety ◽  
Randomized Controlled ◽  
Oral Premedication

scholarly journals Oral Ketorolac with Inferior Alveolar Nerve Block for Irreversible Pulpitis: A Systematic Review and Meta-analysis

2018 ◽  
Vol 12 (1) ◽  
pp. 340-346 ◽  
Author(s):  
Gowri Sivaramakrishnan ◽  
Kannan Sridharan
Keyword(s):  
Systematic Review ◽  
Relative Risk ◽  
Success Rate ◽  
Nerve Block ◽  
Meta Analysis ◽  
Inferior Alveolar Nerve ◽  
Endodontic Treatment ◽  
Inferior Alveolar Nerve Block ◽  
The Mean ◽  
Irreversible Pulpitis

Background: Ketorolac has advantages over other analgesics as a pre-anaesthetic medication. Considering this in mind, the present meta-analysis aims to identify the effect of oral ketorolac premedication on the anaesthetic efficacy of Inferior Alveolar Nerve Block (IANB) in patients with irreversible pulpitis. Methods: Full-texts of eligible studies were obtained from electronic databases. The extracted data was analysed using non-Cochrane mode in RevMan 5.0 software. Relative risk [95% CI] was calculated for the success of IANB. Results: Four studies were included for the final review. The success rate of IANB on 221 patients with relative risk of 1.87 [1.36, 2.56] was statistically significant favouring ketorolac. The mean difference for VAS in 171 patients was not statistically significant {-13.55 [-33.91, 6.82]}. Conclusion: Oral ketorolac can be successfully administered as a premedication before conventional inferior alveolar nerve block for endodontic treatment for irreversible pulpitis.

Sign in / Sign up

Export Citation Format

Share Document